IM Cannabis (IMCC) Income from Discontinued Operations (2021 - 2026)
IM Cannabis' (IMCC) quarterly Income from Discontinued Operations came in at 29897.43 in Q1 2026, up 47.93% year-on-year from 20210.58 in Q1 2025, and up 47.93% quarter-over-quarter from 20210.58 in Q1 2025.
IM Cannabis (IMCC) Income from Discontinued Operations (2021 - 2026) Analysis & Trends
IM Cannabis' Income from Discontinued Operations history runs 6 years deep, the most recent figure standing at 29897.43 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.33 Bn | 18.53 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | - |
| 10 | IM Cannabis | 519,475.19 | -212,647.33 | 1.03 Mn | 29,897.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29,897.43 |
| Mar 31, 2025 | 20,210.58 |
| Jun 30, 2024 | -613,426.92 |
| Mar 31, 2024 | 82,374.57 |
| Jun 30, 2023 | -119,112.39 |
| Mar 31, 2023 | -11,835.14 |
| Sep 30, 2022 | -93,543.04 |
| Jun 30, 2022 | -789,831.04 |
| Mar 31, 2022 | -177,631.97 |
| Sep 30, 2021 | -24,626.69 |